Study design

AG Anna E. Gauthier
CC Courtney E. Chandler
VP Valentina Poli
FG Francesca M. Gardner
AT Aranteiti Tekiau
RS Richard Smith
KB Kevin S. Bonham
EC Erik E. Cordes
TS Timothy M. Shank
IZ Ivan Zanoni
DG David R. Goodlett
SB Steven J. Biller
RE Robert K. Ernst
RR Randi D. Rotjan
JK Jonathan C. Kagan
request Request a Protocol
ask Ask a question
Favorite

We designed this study to evaluate the ability of mammalian PRRs to detect deep-sea bacteria via the PAMP, LPS. Therefore, we cultured bacterial strains from the deep sea of PIPA to screen in a flow cytometry–based assay for their ability to interact with endogenous murine PRRs, CD14 and TLR4. Our results indicated that 80% of live bacteria strains did not engage with murine CD14 and/or TLR4 and were categorized as silent to these PRRs. To confirm that LPS from deep-sea bacteria was silent, we purified LPS from stimulatory and silent Moritella strains to characterize the downstream innate immune response to extracellular and intracellular LPS in murine and human cells. LPS from Moritella strains that were silent to murine and human PRRs did not initiate any downstream innate immune response. LPS from silent Moritella strains also did not engage with murine PRRs in vivo or in L. polyphemus. We then hydrolyzed and purified lipid A from Moritella LPS and confirmed that the activity of silent LPS was a direct result of the structure of the lipid A moiety. To delineate the differences between stimulatory and silent Moritella lipid A, we characterized the structure of lipid A and sequenced the genomes of each strain of interest.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A